65,437 trials
Crohn's Disease
Primary: Percentage of Crohn's Disease Activity Index (CDAI) Responders at Week 26 — 44.4; 73.3; 60.0; 55.6 Percentage of subjects
Hypertension, Pulmonary
Primary: Mean Change From Baseline in Six Minutes Walk Distance (6MWD) at Week 12 — 33.49 Meters
Spondylarthropathies, Enthesitis
Primary: Normalized Net Incremental Area Under the Curve (AUC) for Patient Global Assessment of Disease Activity (PGA) Between Randomization and Week 12 — -28.54; -11.07 mm…
Crohn's Disease
Primary: Percentage of Crohn's Disease Activity Index (CDAI) Responders at Week 34 — 66.7; 28.6; 42.9; 33.3 Percentage of subjects
HIV
Primary: Proportion of Patients Who Maintain Plasma HIV Viral Load Measurements < 400 Copies/ml at 2, 4, 8, 12, 16, 24, 36 and 48 Weeks After Switching to DRV/r and ETR, Missing…
Hypertrophy, Left Ventricular
Primary: Model-adjusted Mean Change From Baseline in Left Ventricular Mass Indexed (LVMI) by Body Surface Area as Measured by Magnetic Resonance Imaging (MRI) at Month 12…
Atrial Fibrillation
Primary: Treatment Failure — 184; 141 participants — p=<0.0001
Hypertension
Primary: Change From Baseline to Week 6 in 24 Hour (hr) Mean Diastolic Blood Pressure — -5.79; -8.11; -7.37; -4.40 mmHg — p=>0.1
Generalized Anxiety Disorder
Primary: Number of Subjects at Endpoint (Post Alprazolam Free Week 6 or Last Observation Carried Forward [LOCF] Post Alprazolam Free Week 1) Who Are Benzodiazepine Free — 20; 10…
Hypercholesterolemia
Primary: Number of Participants Reaching the LDL-C (Low Density Lipoprotein-Cholesterol) Goal (< 100 mg/dl) After 6 Weeks of Treatment — 89; 63 Participants
Chemotherapy-Induced Nausea and Vomiting
Primary: Number of Patients Who Reported No Vomiting — 324; 252 Participants — p=<0.01
Dyslipidemia · Hypertension
Primary: Subjects With Blood Pressure (BP) <140/90 Millimeters of Mercury (mmHg) and Low Density Lipoprotein Cholesterol (LDL-C) <100 Milligrams Per Deciliter(mg/dL) at Week 6…
Sleep Initiation and Maintenance Disorders
Primary: Mean Latency to Persistent Sleep Via Polysomnography (Nights 1-2). — 67.0; 41.7 minutes — p=<0.001
Dyslipidemias · Coronary Heart Disease · Combined (Atherogenic) Dyslipidemia
Primary: Median Percent Change in Triglycerides From Baseline to Final Visit — -57.3; -39.7 Percent change — p=< 0.001
Healthy
Primary: Maximum Plasma Concentration (Cmax) — 3,569.47; 10,708.40; 11,014.93; 11,202.87 ng/mL